[go: up one dir, main page]

DE60025958D1 - 14,15-BETA-METHYLENE SUBSTITUTED ANDROGENE - Google Patents

14,15-BETA-METHYLENE SUBSTITUTED ANDROGENE

Info

Publication number
DE60025958D1
DE60025958D1 DE60025958T DE60025958T DE60025958D1 DE 60025958 D1 DE60025958 D1 DE 60025958D1 DE 60025958 T DE60025958 T DE 60025958T DE 60025958 T DE60025958 T DE 60025958T DE 60025958 D1 DE60025958 D1 DE 60025958D1
Authority
DE
Germany
Prior art keywords
androgene
beta
methylene substituted
methylene
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60025958T
Other languages
German (de)
Other versions
DE60025958T2 (en
Inventor
Dirk Leysen
Der Louw Jaap Van
Bursi Roberta Buma
Gooyer Evert De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of DE60025958D1 publication Critical patent/DE60025958D1/en
Application granted granted Critical
Publication of DE60025958T2 publication Critical patent/DE60025958T2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
DE60025958T 1999-12-02 2000-11-29 14,15-BETA-METHYLENE SUBSTITUTED ANDROGENE Expired - Lifetime DE60025958T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99204080 1999-12-02
EP99204080 1999-12-02
PCT/EP2000/012009 WO2001040255A2 (en) 1999-12-02 2000-11-29 14,15-beta-methylene substituted androgens

Publications (2)

Publication Number Publication Date
DE60025958D1 true DE60025958D1 (en) 2006-04-20
DE60025958T2 DE60025958T2 (en) 2006-07-27

Family

ID=8240955

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025958T Expired - Lifetime DE60025958T2 (en) 1999-12-02 2000-11-29 14,15-BETA-METHYLENE SUBSTITUTED ANDROGENE

Country Status (27)

Country Link
US (1) US6706700B2 (en)
EP (1) EP1237904B1 (en)
JP (1) JP2003515543A (en)
CN (1) CN1166680C (en)
AR (1) AR026655A1 (en)
AT (1) ATE317396T1 (en)
AU (1) AU778017B2 (en)
CA (1) CA2390226A1 (en)
CO (1) CO5251441A1 (en)
CY (1) CY1106086T1 (en)
CZ (1) CZ301376B6 (en)
DE (1) DE60025958T2 (en)
DK (1) DK1237904T3 (en)
ES (1) ES2258037T3 (en)
HK (1) HK1047596B (en)
HU (1) HUP0203611A3 (en)
IL (1) IL149424A (en)
MX (1) MXPA02004939A (en)
NO (1) NO322422B1 (en)
NZ (1) NZ518753A (en)
PE (1) PE20011033A1 (en)
PL (1) PL202999B1 (en)
RU (1) RU2242479C2 (en)
SK (1) SK287095B6 (en)
TW (1) TWI275593B (en)
WO (1) WO2001040255A2 (en)
ZA (1) ZA200203536B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60004377T2 (en) * 1999-04-06 2004-06-09 Akzo Nobel N.V. ORAL EFFECTIVE 7-ALPHA-ALKYL ANDROGENE
MXPA04007049A (en) * 2002-01-21 2004-10-14 Akzo Nobel Nv PROCESS FOR THE PREPARATION OF 7alpha-METHYLSTEROIDS.
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
KR102007874B1 (en) * 2011-10-07 2019-08-06 에스테트라 에스.피.알.엘. Process for the production of estetrol
UA123098C2 (en) 2015-06-18 2021-02-17 Естетра Спрл DISPOSABLE UNIT OF DOSAGE CONTAINING AN ESTETRAL COMPONENT DISPERSED IN THE ORAL CAVITY
PE20180522A1 (en) 2015-06-18 2018-03-14 Mithra Pharmaceuticals S A ORODISPERSABLE DOSING UNIT CONTAINING A STETROL COMPONENT
CA2988485A1 (en) 2015-06-18 2016-12-22 Mithra Pharmaceuticals S.A. Orodispersible tablet containing estetrol
EP3310346B1 (en) 2015-06-18 2021-03-24 Estetra SPRL Orodispersible tablet containing estetrol
KR102712911B1 (en) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 Method for the management of dysmenorrhea and menstrual pain
TWI801561B (en) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 Compounds and their uses for alleviating menopause-associated symptoms
JOP20200260A1 (en) 2018-04-19 2019-10-19 Estetra Sprl Compounds and their uses for alleviating menopause-associated symptoms
TWI893101B (en) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 Contraceptive compositions with reduced adverse effects
CN111621141B (en) * 2020-06-12 2022-04-08 广西大学 A slow-release chlorine dioxide-water-based polyurethane antibacterial film and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
DE19537626A1 (en) * 1995-10-10 1997-04-17 Jenapharm Gmbh Steroids with a 14, 15 methylene group
DE19827522A1 (en) * 1998-06-22 1999-12-23 Jenapharm Gmbh New derivatives of 19-norandrostane useful in fertility control or treatment of e.g. endometriosis, mammary carcinoma or hypogonadism
EP1163259B1 (en) * 1999-03-08 2002-11-20 Akzo Nobel N.V. 14.beta.,17-alpha-hydroxymethylandrostane derivatives as androgens

Also Published As

Publication number Publication date
CN1166680C (en) 2004-09-15
EP1237904A2 (en) 2002-09-11
TWI275593B (en) 2007-03-11
RU2242479C2 (en) 2004-12-20
SK287095B6 (en) 2009-12-07
WO2001040255A3 (en) 2001-11-15
HUP0203611A2 (en) 2003-03-28
HK1047596A1 (en) 2003-02-28
CO5251441A1 (en) 2003-02-28
JP2003515543A (en) 2003-05-07
US20030100543A1 (en) 2003-05-29
IL149424A (en) 2007-05-15
IL149424A0 (en) 2002-11-10
PL355689A1 (en) 2004-05-17
ES2258037T3 (en) 2006-08-16
EP1237904B1 (en) 2006-02-08
CN1402735A (en) 2003-03-12
NZ518753A (en) 2004-05-28
AR026655A1 (en) 2003-02-19
CA2390226A1 (en) 2001-06-07
NO322422B1 (en) 2006-10-02
MXPA02004939A (en) 2003-05-23
DK1237904T3 (en) 2006-06-06
ZA200203536B (en) 2003-08-04
WO2001040255A2 (en) 2001-06-07
CZ20021894A3 (en) 2002-08-14
DE60025958T2 (en) 2006-07-27
NO20022564D0 (en) 2002-05-30
SK7582002A3 (en) 2002-09-10
PE20011033A1 (en) 2001-10-11
NO20022564L (en) 2002-05-30
AU2838301A (en) 2001-06-12
HK1047596B (en) 2006-04-21
CY1106086T1 (en) 2011-06-08
AU778017B2 (en) 2004-11-11
PL202999B1 (en) 2009-08-31
HUP0203611A3 (en) 2004-07-28
CZ301376B6 (en) 2010-02-03
US6706700B2 (en) 2004-03-16
ATE317396T1 (en) 2006-02-15

Similar Documents

Publication Publication Date Title
ID29241A (en) TERANELASI KINOLIN DISTRICTS-1,2
DE69933287D1 (en) 12,13-MODIFIED EPOTHILON DERIVATIVES
MA25499A1 (en) CONTACTOR-CIRCUIT-BREAKER.
MA26849A1 (en) 4-pyridinyl-N-ACYL-L-phenylalanine.
ID28483A (en) 2- (3,5-BIS-TRIFLUOROMETYL-PHENIL) -METIL-N- (6-MORFOLIN-4-IL-4-0-TOLYL-PYRIDIN-3-IL) -ISOBUTIRAMIDA
PT1210349E (en) PYRAZOLO-¬4,3-D | -PYRIMIDINES
DE50107988D1 (en) SUBSTITUTED 1,2,3,4-TETRAHYDROCHINOLIN-2-CARBOXYLENE DERIVATIVES
DE60025958D1 (en) 14,15-BETA-METHYLENE SUBSTITUTED ANDROGENE
NO20003825L (en) 1,3,4 - oxadiazolone derivatives
ITBO990359A0 (en) ELECTROSPINDLE.
DE60029755D1 (en) CONGAWANDSCHUTZ.
ATE234839T1 (en) 4,5-AZOLO-OXINDOLES
EP1192168A4 (en) GALECTINE 11
ITBO990358A0 (en) ELECTROSPINDLE.
ID26368A (en) DECREASED 2, HYDROMICIN DEXY
ES1042496Y (en) "PILONA SUBIBLE".
ES1044367Y (en) IMPROVED PIÑATA.
ES1044838Y (en) FRIEGASUELOS.
ITSS990004V0 (en) PYRAMID - REMEMBER.
ITCS990004V0 (en) "TERMOCAMIN0 C.C.M."
DE60017150D1 (en) 1,4,5,6-Tetra-Hydropropylidene-Derivatives as VITRONECTIN-INHIBITORS
ES1044013Y (en) NEW IMPROVED CANTONERA.
IT1313922B1 (en) IMPROVED ELECTROSPINDLE.
ES1042809Y (en) IMPROVED SPONGE-SCRAP.
IT247637Y1 (en) Tritapepe.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: N.V. ORGANON, OSS, NL